West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 791,300 | 628,500 | 509,700 | 404,200 | 484,600 |
| Receivables | 574,400 | 625,000 | 582,400 | 543,600 | 552,500 |
| Inventories | 443,900 | 438,000 | 421,100 | 388,700 | 377,000 |
| Other current assets | 168,600 | 131,800 | 167,700 | 121,000 | 124,000 |
| TOTAL | $1,978,200 | $1,823,300 | $1,680,900 | $1,457,500 | $1,538,100 |
| Non-Current Assets | |||||
| PPE Net | 1,726,400 | 1,740,600 | 1,722,000 | 1,631,700 | 1,581,600 |
| Investments And Advances | 212,300 | 220,900 | 224,700 | 211,900 | 202,100 |
| Intangibles | 117,600 | 119,500 | 120,600 | 117,500 | 116,800 |
| Other Non-Current Assets | 235,500 | 201,500 | 204,600 | 199,600 | 204,800 |
| TOTAL | $2,291,800 | $2,282,500 | $2,271,900 | $2,160,700 | $2,105,300 |
| Total Assets | $4,270,000 | $4,105,800 | $3,952,800 | $3,618,200 | $3,643,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 253,700 | 255,800 | 239,000 | 228,400 | 239,300 |
| Accrued Expenses | 135,900 | 111,800 | 93,400 | 67,800 | 73,500 |
| Other current liabilities | 214,500 | 213,100 | 222,800 | 186,400 | 188,200 |
| TOTAL | $654,900 | $635,400 | $604,600 | $526,700 | $550,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 202,800 | 202,700 | 202,600 | 202,600 | 202,600 |
| Other Non-Current Liabilities | 199,800 | 179,900 | 181,000 | 173,100 | 172,200 |
| TOTAL | $439,100 | $418,900 | $419,100 | $408,400 | $410,700 |
| Total Liabilities | $1,094,000 | $1,054,300 | $1,023,700 | $935,100 | $961,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,021 | 71,943 | 71,907 | 71,845 | 72,304 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 4,374,900 | 4,262,400 | 4,139,200 | 4,031,200 | 3,956,600 |
| Other shareholders' equity | -105,700 | -102,700 | -88,900 | -205,700 | -258,200 |
| TOTAL | $3,176,000 | $3,051,500 | $2,929,100 | $2,683,100 | $2,682,300 |
| Total Liabilities And Equity | $4,270,000 | $4,105,800 | $3,952,800 | $3,618,200 | $3,643,400 |